dilevalol has been researched along with drf 2725 in 1 studies
| Studies (dilevalol) | Trials (dilevalol) | Recent Studies (post-2010) (dilevalol) | Studies (drf 2725) | Trials (drf 2725) | Recent Studies (post-2010) (drf 2725) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 41 | 3 | 4 |
| Protein | Taxonomy | dilevalol (IC50) | drf 2725 (IC50) |
|---|---|---|---|
| Chain A, peroxisome proliferator activated receptor gamma | Homo sapiens (human) | 0.092 | |
| Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 0.092 | |
| Peroxisome proliferator-activated receptor alpha | Homo sapiens (human) | 0.98 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
1 other study(ies) available for dilevalol and drf 2725
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |